The client experience of psychiatric medication: A qualitative study

Jeffrey R. Lacasse, Megan Hayes Piel, Cynthia A. Lietz, Ann Rider, Jacob Z. Hess

Research output: Contribution to journalArticle

Abstract

This qualitative study examined the client experience of psychiatric medication among an unusual and under-studied subpopulation, individuals diagnosed with SMI who eventually experienced functional recovery. Four themes emerged from in-depth qualitative interviews with 16 such individuals: (1) primacy of medication, (2) informed consent, (3) self-determination, and (4) clinical engagement. Participants reported that psychiatric medication was the primary, and sometimes the only, intervention offered to them. Some described substantial delays in receiving psychosocial services, or that they were not informed of their availability. Participants also identified deficiencies in the process of informed consent, with some receiving information on adverse effects belatedly, or not at all. Coercive medication practices (e.g., court-ordered medication) were described negatively. Good clinical engagement from prescribers (e.g., good listening and a respectful relationship) was highly appreciated by the participants and seen as an essential component of their recovery process. Poor clinical engagement on the part of prescribers was a source of frustration. In some cases this resulted from poor micro-level skills; in others, it was more reflective of systemic problems (e.g., 15-minute med checks or rotating prescribers). The participants in this study had all attained functional recovery, an unusually positive outcome. Thus, their experiences and insights could have utility. As recovery-oriented mental health services expand, the integration of client voice into the use of psychiatric medications could result in more collaborative, and possibly more effective, mental health treatment.

LanguageEnglish (US)
Pages61-81
Number of pages21
JournalSocial Work in Mental Health
Volume14
Issue number1
DOIs
StatePublished - Jan 2 2016
Externally publishedYes

Fingerprint

Psychiatry
medication
Informed Consent
Personal Autonomy
experience
Frustration
Mental Health Services
Mental Health
mental health
Interviews
frustration
self-determination
micro level
qualitative interview
health service

Keywords

  • clinical engagement
  • informed consent
  • microskills
  • Psychiatric medication
  • relationship

ASJC Scopus subject areas

  • Social Sciences (miscellaneous)
  • Public Health, Environmental and Occupational Health

Cite this

The client experience of psychiatric medication : A qualitative study. / Lacasse, Jeffrey R.; Hayes Piel, Megan; Lietz, Cynthia A.; Rider, Ann; Hess, Jacob Z.

In: Social Work in Mental Health, Vol. 14, No. 1, 02.01.2016, p. 61-81.

Research output: Contribution to journalArticle

Lacasse, JR, Hayes Piel, M, Lietz, CA, Rider, A & Hess, JZ 2016, 'The client experience of psychiatric medication: A qualitative study' Social Work in Mental Health, vol. 14, no. 1, pp. 61-81. DOI: 10.1080/15332985.2015.1058312
Lacasse JR, Hayes Piel M, Lietz CA, Rider A, Hess JZ. The client experience of psychiatric medication: A qualitative study. Social Work in Mental Health. 2016 Jan 2;14(1):61-81. Available from, DOI: 10.1080/15332985.2015.1058312
Lacasse, Jeffrey R. ; Hayes Piel, Megan ; Lietz, Cynthia A. ; Rider, Ann ; Hess, Jacob Z./ The client experience of psychiatric medication : A qualitative study. In: Social Work in Mental Health. 2016 ; Vol. 14, No. 1. pp. 61-81
@article{af4925dd9b9541339b0ea9cbfcb8c41c,
title = "The client experience of psychiatric medication: A qualitative study",
abstract = "This qualitative study examined the client experience of psychiatric medication among an unusual and under-studied subpopulation, individuals diagnosed with SMI who eventually experienced functional recovery. Four themes emerged from in-depth qualitative interviews with 16 such individuals: (1) primacy of medication, (2) informed consent, (3) self-determination, and (4) clinical engagement. Participants reported that psychiatric medication was the primary, and sometimes the only, intervention offered to them. Some described substantial delays in receiving psychosocial services, or that they were not informed of their availability. Participants also identified deficiencies in the process of informed consent, with some receiving information on adverse effects belatedly, or not at all. Coercive medication practices (e.g., court-ordered medication) were described negatively. Good clinical engagement from prescribers (e.g., good listening and a respectful relationship) was highly appreciated by the participants and seen as an essential component of their recovery process. Poor clinical engagement on the part of prescribers was a source of frustration. In some cases this resulted from poor micro-level skills; in others, it was more reflective of systemic problems (e.g., 15-minute med checks or rotating prescribers). The participants in this study had all attained functional recovery, an unusually positive outcome. Thus, their experiences and insights could have utility. As recovery-oriented mental health services expand, the integration of client voice into the use of psychiatric medications could result in more collaborative, and possibly more effective, mental health treatment.",
keywords = "clinical engagement, informed consent, microskills, Psychiatric medication, relationship",
author = "Lacasse, {Jeffrey R.} and {Hayes Piel}, Megan and Lietz, {Cynthia A.} and Ann Rider and Hess, {Jacob Z.}",
year = "2016",
month = "1",
day = "2",
doi = "10.1080/15332985.2015.1058312",
language = "English (US)",
volume = "14",
pages = "61--81",
journal = "Social Work in Mental Health",
issn = "1533-2985",
publisher = "Routledge",
number = "1",

}

TY - JOUR

T1 - The client experience of psychiatric medication

T2 - Social Work in Mental Health

AU - Lacasse,Jeffrey R.

AU - Hayes Piel,Megan

AU - Lietz,Cynthia A.

AU - Rider,Ann

AU - Hess,Jacob Z.

PY - 2016/1/2

Y1 - 2016/1/2

N2 - This qualitative study examined the client experience of psychiatric medication among an unusual and under-studied subpopulation, individuals diagnosed with SMI who eventually experienced functional recovery. Four themes emerged from in-depth qualitative interviews with 16 such individuals: (1) primacy of medication, (2) informed consent, (3) self-determination, and (4) clinical engagement. Participants reported that psychiatric medication was the primary, and sometimes the only, intervention offered to them. Some described substantial delays in receiving psychosocial services, or that they were not informed of their availability. Participants also identified deficiencies in the process of informed consent, with some receiving information on adverse effects belatedly, or not at all. Coercive medication practices (e.g., court-ordered medication) were described negatively. Good clinical engagement from prescribers (e.g., good listening and a respectful relationship) was highly appreciated by the participants and seen as an essential component of their recovery process. Poor clinical engagement on the part of prescribers was a source of frustration. In some cases this resulted from poor micro-level skills; in others, it was more reflective of systemic problems (e.g., 15-minute med checks or rotating prescribers). The participants in this study had all attained functional recovery, an unusually positive outcome. Thus, their experiences and insights could have utility. As recovery-oriented mental health services expand, the integration of client voice into the use of psychiatric medications could result in more collaborative, and possibly more effective, mental health treatment.

AB - This qualitative study examined the client experience of psychiatric medication among an unusual and under-studied subpopulation, individuals diagnosed with SMI who eventually experienced functional recovery. Four themes emerged from in-depth qualitative interviews with 16 such individuals: (1) primacy of medication, (2) informed consent, (3) self-determination, and (4) clinical engagement. Participants reported that psychiatric medication was the primary, and sometimes the only, intervention offered to them. Some described substantial delays in receiving psychosocial services, or that they were not informed of their availability. Participants also identified deficiencies in the process of informed consent, with some receiving information on adverse effects belatedly, or not at all. Coercive medication practices (e.g., court-ordered medication) were described negatively. Good clinical engagement from prescribers (e.g., good listening and a respectful relationship) was highly appreciated by the participants and seen as an essential component of their recovery process. Poor clinical engagement on the part of prescribers was a source of frustration. In some cases this resulted from poor micro-level skills; in others, it was more reflective of systemic problems (e.g., 15-minute med checks or rotating prescribers). The participants in this study had all attained functional recovery, an unusually positive outcome. Thus, their experiences and insights could have utility. As recovery-oriented mental health services expand, the integration of client voice into the use of psychiatric medications could result in more collaborative, and possibly more effective, mental health treatment.

KW - clinical engagement

KW - informed consent

KW - microskills

KW - Psychiatric medication

KW - relationship

UR - http://www.scopus.com/inward/record.url?scp=84951106540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951106540&partnerID=8YFLogxK

U2 - 10.1080/15332985.2015.1058312

DO - 10.1080/15332985.2015.1058312

M3 - Article

VL - 14

SP - 61

EP - 81

JO - Social Work in Mental Health

JF - Social Work in Mental Health

SN - 1533-2985

IS - 1

ER -